APA (7th ed.) Citation

S, D., TM, G., RJ, H., JA, S., W, V. C., L, V. N., . . . IM, v. O. (2017). Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics - a decision analytical model. BJU international, 120(5), 659. https://doi.org/10.1111/bju.13861

Chicago Style (17th ed.) Citation

S, Dijkstra, Govers TM, Hendriks RJ, Schalken JA, Van Criekinge W, Van Neste L, Grutters JPC, Sedelaar JPM, and van Oort IM. "Cost-effectiveness of a New Urinary Biomarker-based Risk Score Compared to Standard of Care in Prostate Cancer Diagnostics - a Decision Analytical Model." BJU International 120, no. 5 (2017): 659. https://doi.org/10.1111/bju.13861.

MLA (9th ed.) Citation

S, Dijkstra, et al. "Cost-effectiveness of a New Urinary Biomarker-based Risk Score Compared to Standard of Care in Prostate Cancer Diagnostics - a Decision Analytical Model." BJU International, vol. 120, no. 5, 2017, p. 659, https://doi.org/10.1111/bju.13861.